|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.890 EUR | +2.16% |
|
-0.53% | +32.67% |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| 06-22 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended May 2026 | CI |
| Market Cap | 1.9B 1.14B 999M 922M 849M 1.6B 110B 1.64B 11.02B 4.33B 53.9B 4.29B 4.2B 186B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44B 1.47B 1.28B 1.18B 1.09B 2.06B 141B 2.1B 14.15B 5.57B 69.23B 5.51B 5.39B 238B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 day | +2.16% | ||
| 1 week | -0.53% | ||
| Current month | -2.07% | ||
| 1 month | -0.53% | ||
| 3 months | +8.00% | ||
| 6 months | -4.79% | ||
| Current year | +32.67% |
| 1 week | 1.85 |  | 1.9 |
| 1 month | 1.85 | | 1.94 |
| Current year | 1.41 | | 2 |
| 1 year | 1.21 | | 2 |
| 3 years | 0.89 | | 2 |
| 5 years | 0.58 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 30/09/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 31/12/2001 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 18/05/2010 |
| Director/Board Member | 63 | 18/05/2010 | |
| Director/Board Member | 61 | 11/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 29/09/20 | Buy | Chief Executive Officer | 1,000 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | -0.53% | +45.45% | +112.41% | 1.14B | |
| -5.05% | -0.21% | -20.55% | -32.27% | 15.14B | |
| -3.17% | -3.17% | -27.59% | -35.26% | 6.93B | |
| +2.53% | +4.48% | -20.75% | -1.77% | 6.13B | |
| -2.80% | +3.58% | -11.74% | -31.41% | 3.73B | |
| -3.53% | +5.21% | +7.97% | -31.30% | 3.12B | |
| +2.36% | +1.93% | -37.73% | -10.94% | 3.25B | |
| -0.11% | -1.03% | -30.41% | -49.47% | 3.15B | |
| +0.37% | -1.07% | +94.71% | - | 2.57B | |
| +0.98% | +3.41% | -18.63% | -1.07% | 2.53B | |
| Average | -0.63% | +0.96% | -1.93% | -9.01% | 4.77B | |
| Weighted average by Cap. | -1.91% | +0.61% | -12.98% | -22.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.12B 1.04B 955M 1.8B 124B 1.84B 12.39B 4.87B 60.61B 4.83B 4.72B 209B | 2.63B 1.58B 1.38B 1.28B 1.18B 2.22B 152B 2.26B 15.24B 5.99B 74.58B 5.94B 5.81B 257B |
| Net income | 77.85M 46.75M 40.86M 37.7M 34.75M 65.5M 4.5B 66.96M 451M 177M 2.21B 176M 172M 7.59B | 134M 80.19M 70.08M 64.67M 59.61M 112M 7.72B 115M 773M 304M 3.78B 301M 295M 13.02B |
| Net Debt | 444M 267M 233M 215M 198M 374M 25.69B 382M 2.57B 1.01B 12.58B 1B 980M 43.31B | 541M 325M 284M 262M 242M 455M 31.31B 466M 3.13B 1.23B 15.33B 1.22B 1.19B 52.78B |
Employees
6,005
Sector
Drug Retailers
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | €1.890 | +2.16% | 2,681 |
| 16/07/26 | €1.850 | -1.60% | 895 |
| 15/07/26 | €1.880 | 0.00% | 7,079 |
| 14/07/26 | €1.880 | -0.79% | 2,724 |
| 13/07/26 | €1.895 | -0.26% | 5,009 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
